Fusion Biopsy Market Size, Share, Trends, Industry Analysis Report: By Biopsy Route (Transrectal and Transperineal), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Description

List of Tables

The global Fusion Biopsy market size is expected to reach USD 1,677.18 Million by 2034, according to a new study by Polaris Market Research. The report "Fusion Biopsy Market Size, Share, Trends, Industry Analysis Report: By Biopsy Route (Transrectal and Transperineal), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Fusion biopsy is a medical procedure that combines real-time ultrasound imaging with pre-acquired MRI images to guide the biopsy of suspicious prostate areas. This technique improves the accuracy of detecting prostate cancer compared to standard biopsy methods.

The fusion biopsy market is experiencing significant growth, driven by the rising prevalence of prostate cancer and the increasing adoption of precision diagnostic techniques. Key trends in this market include technological innovation, such as advancements in imaging and AI integration, and strategic collaborations between companies and healthcare providers. The market is also witnessing a growing emphasis on the transperineal biopsy route due to its improved cancer detection capabilities.

Fusion Biopsy Market Report Highlights:

By biopsy route, transrectal segment has been the dominant route in the fusion biopsy market. This is attributed to the fact that many commercially available fusion biopsy systems are designed for the transrectal approach.

By end use, hospitals constitute the largest market share in the fusion biopsy market. This is due to their well-established infrastructure, availability of advanced equipment like MRI scanners, and the presence of specialized medical staff.

By region, North America currently holds a prominent position in the fusion biopsy market. Asia Pacific is emerging as the region with the highest growth rate in the fusion biopsy market.

Key players in the Fusion Biopsy market include BK Medical Holding Company, Inc., Eigen, ESAOTE S.p.A., Exact Imaging, Focal Healthcare, Hitachi, Ltd., KOELIS, Koninklijke Philips N.V., and MedCom.

Polaris Market Research has segmented the Fusion Biopsy market report based on biopsy route, end use, and region:

By Biospy Route Outlook (Revenue-USD Million, 2020-2034)

Transrectal

Transperineal

By End Use Outlook (Revenue-USD Million, 2020-2034)

Hospitals

Diagnostic Centers

Ambulatory Care Centers

By Regional Outlook (Revenue-USD Million, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM5662

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Fusion Biopsy Market Insights

4.1. Fusion Biopsy Market - Market Snapshot
4.2. Fusion Biopsy Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Prostate Cancer
  - 4.2.1.2. Technological Advancements in Imaging
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Limited availability of skilled professionals
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Fusion Biopsy Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Fusion Biopsy Market, by Biopsy Route

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
5.3. Transrectal
- 5.3.1. Global Fusion Biopsy Market, by Transrectal, by Region, 2020-2034 (USD Million)
5.4. Transperineal
- 5.4.1. Global Fusion Biopsy Market, by Transperineal, by Region, 2020-2034 (USD Million)

6. Global Fusion Biopsy Market, by End Use

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
6.3. Hospitals
- 6.3.1. Global Fusion Biopsy Market, by Hospitals, by Region, 2020-2034 (USD Million)
6.4. Diagnostic Centers
- 6.4.1. Global Fusion Biopsy Market, by Diagnostic Centers, by Region, 2020-2034 (USD Million)
6.5. Ambulatory Care Centers
- 6.5.1. Global Fusion Biopsy Market, by Ambulatory Care Centers, by Region, 2020-2034 (USD Million)

7. Global Fusion Biopsy Market, by Geography

7.1. Key Findings
7.2. Introduction
- 7.2.1. Fusion Biopsy Market Assessment, By Geography, 2020-2034 (USD Million)
7.3. Fusion Biopsy Market - North America
- 7.3.1. North America: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
- 7.3.2. North America: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.3.3. Fusion Biopsy Market - U.S.
  - 7.3.3.1. U.S.: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.3.3.2. U.S.: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.3.4. Fusion Biopsy Market - Canada
  - 7.3.4.1. Canada: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.3.4.2. Canada: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
7.4. Fusion Biopsy Market - Europe
- 7.4.1. Europe: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
- 7.4.2. Europe: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.4.3. Fusion Biopsy Market - UK
  - 7.4.3.1. UK: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.4.3.2. UK: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.4.4. Fusion Biopsy Market - France
  - 7.4.4.1. France: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.4.4.2. France: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.4.5. Fusion Biopsy Market - Germany
  - 7.4.5.1. Germany: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.4.5.2. Germany: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.4.6. Fusion Biopsy Market - Italy
  - 7.4.6.1. Italy: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.4.6.2. Italy: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.4.7. Fusion Biopsy Market - Spain
  - 7.4.7.1. Spain: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.4.7.2. Spain: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.4.8. Fusion Biopsy Market - Netherlands
  - 7.4.8.1. Netherlands: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.4.8.2. Netherlands: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.4.9. Fusion Biopsy Market - Russia
  - 7.4.9.1. Russia: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.4.9.2. Russia: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.4.10. Fusion Biopsy Market - Rest of Europe
  - 7.4.10.1. Rest of Europe: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.4.10.2. Rest of Europe: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
7.5. Fusion Biopsy Market - Asia Pacific
- 7.5.1. Asia Pacific: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
- 7.5.2. Asia Pacific: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.5.3. Fusion Biopsy Market - China
  - 7.5.3.1. China: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.5.3.2. China: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.5.4. Fusion Biopsy Market - India
  - 7.5.4.1. India: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.5.4.2. India: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.5.5. Fusion Biopsy Market - Malaysia
  - 7.5.5.1. Malaysia: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.5.5.2. Malaysia: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.5.6. Fusion Biopsy Market - Japan
  - 7.5.6.1. Japan: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.5.6.2. Japan: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.5.7. Fusion Biopsy Market - Indonesia
  - 7.5.7.1. Indonesia: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.5.7.2. Indonesia: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.5.8. Fusion Biopsy Market - South Korea
  - 7.5.8.1. South Korea: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.5.8.2. South Korea: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.5.9. Fusion Biopsy Market - Australia
  - 7.5.9.1. Australia: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.5.9.2. Australia: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.5.10. Fusion Biopsy Market - Rest of Asia Pacific
  - 7.5.10.1. Rest of Asia Pacific: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.5.10.2. Rest of Asia Pacific: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
7.6. Fusion Biopsy Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
- 7.6.2. Middle East & Africa: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.6.3. Fusion Biopsy Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.6.3.2. Saudi Arabia: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.6.4. Fusion Biopsy Market - UAE
  - 7.6.4.1. UAE: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.6.4.2. UAE: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.6.5. Fusion Biopsy Market - Israel
  - 7.6.5.1. Israel: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.6.5.2. Israel: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.6.6. Fusion Biopsy Market - South Africa
  - 7.6.6.1. South Africa: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.6.6.2. South Africa: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.6.7. Fusion Biopsy Market - Rest of Middle East & Africa
  - 7.6.7.1. Rest of Middle East & Africa: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.6.7.2. Rest of Middle East & Africa: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
7.7. Fusion Biopsy Market - Latin America
- 7.7.1. Latin America: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
- 7.7.2. Latin America: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.7.3. Fusion Biopsy Market - Mexico
  - 7.7.3.1. Mexico: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.7.3.2. Mexico: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.7.4. Fusion Biopsy Market - Brazil
  - 7.7.4.1. Brazil: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.7.4.2. Brazil: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.7.5. Fusion Biopsy Market - Argentina
  - 7.7.5.1. Argentina: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.7.5.2. Argentina: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)
- 7.7.6. Fusion Biopsy Market - Rest of Latin America
  - 7.7.6.1. Rest of Latin America: Fusion Biopsy Market, by Biopsy Route, 2020-2034 (USD Million)
  - 7.7.6.2. Rest of Latin America: Fusion Biopsy Market, by End Use, 2020-2034 (USD Million)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. BK Medical Holding Company, Inc.
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. Eigen
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. ESAOTE S.p.A.
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Exact Imaging
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. Focal Healthcare
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. Hitachi, Ltd.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. KOELIS
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Koninklijke Philips N.V.
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. MedCom
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development